Results 1-20 of 927 for in the 'Written Answers' speaker:Ian Gibson

Written Answers — Environment Food and Rural Affairs: Food Supply (21 May 2009)

Ian Gibson: To ask the Secretary of State for Environment, Food and Rural Affairs (1) what recent discussions he has had on the inclusion of proposals to address hunger and food scarcity in his Department's forthcoming White Paper on food security; (2) what recent discussions he has had in relation to the inclusion of relief and social protection measures in his Department's forthcoming White Paper on...

Written Answers — Environment Food and Rural Affairs: Food Supply (19 May 2009)

Ian Gibson: To ask the Secretary of State for Environment, Food and Rural Affairs what his most recent assessment is of progress in the delivery of the Government's commitment to the right to food as a fundamental human right.

Written Answers — Energy and Climate Change: Mineral Resources: International Cooperation (18 May 2009)

Ian Gibson: To ask the Secretary of State for Energy and Climate Change what discussions he has had with the Secretary of State for Foreign and Commonwealth Affairs on the Government's strategy for preservation of global mineral resources.

Written Answers — Health: Cancer: Health Services (12 May 2009)

Ian Gibson: To ask the Secretary of State for Health what plans (a) his Department and (b) the National Institute for Health and Clinical Excellence has to provide (i) cancer and (ii) cancer-related lymphoedema patients equal access to specialist NHS treatment in each region.

Written Answers — Treasury: Taxation: Bingo (7 May 2009)

Ian Gibson: To ask the Chancellor of the Exchequer (1) what assessment he has made of the effect on the bingo industry of the changes to taxation announced in the 2009 Budget; (2) what estimate he has made of the net change in revenue to the Exchequer from changes to the taxation of bingo clubs announced in the 2009 Budget.

Written Answers — Health: NHS: Drugs (6 May 2009)

Ian Gibson: To ask the Secretary of State for Health what procedures the National Institute for Health and Clinical Excellence follows to determine the order of priority in which it makes appraisals of particular drugs.

Written Answers — Health: NHS: Drugs (6 May 2009)

Ian Gibson: To ask the Secretary of State for Health pursuant to the answer of 18 March 2009, Official Report, column 1235W, on orphan drugs, when he expects to publish the Government's response to the consultation.

Written Answers — Home Department: Deportation: Zimbabwe (5 May 2009)

Ian Gibson: To ask the Secretary of State for the Home Department if she will suspend all deportations of people to Zimbabwe until there is greater political stability in that country.

Written Answers — Treasury: Research and Development Tax Credit (5 May 2009)

Ian Gibson: To ask the Chancellor of the Exchequer how many companies operating in the UK's life sciences sector have received research and development tax credits in each of the last three years; and what proportion of those were (a) large companies and (b) small and medium-sized enterprises.

Written Answers — Health: Orphan Drugs (29 Apr 2009)

Ian Gibson: To ask the Secretary of State for Health what his Department's definition of (a) orphan and (b) ultra-orphan drugs is.

Written Answers — Health: Cancer: Drugs (21 Apr 2009)

Ian Gibson: To ask the Secretary of State for Health when the National Institute for Health and Clinical Excellence will produce its guidance on the use of (a) bevacizumab, (b) sorafenib, (c) sunitinib (second-line) and (d) temsirolimus for the treatment of advanced and metastatic renal cell carcinoma in the NHS.

Written Answers — Home Department: Drugs: Crime (20 Apr 2009)

Ian Gibson: To ask the Secretary of State for the Home Department which drugs fall into Class (a) A, (b) B and (c) C under the Misuse of Drugs Act 1971; and what estimate she has made of the number of users of each drug in each class.

Written Answers — Health: Drugs: Misuse (1 Apr 2009)

Ian Gibson: To ask the Secretary of State for Health how many drug-related hospital admissions were attributable to each drug in class (a) A, (b) B and (c) C in the last 12 months for which figures are available.

Written Answers — Energy and Climate Change: Parliament: Energy Conservation (30 Mar 2009)

Ian Gibson: To ask the Secretary of State for Energy and Climate Change if he will hold discussions with the authorities of (a) the House of Commons and (b) the House of Lords on measures to reduce energy loss from the Parliamentary estate.

Written Answers — Duchy of Lancaster: Death: Drugs (30 Mar 2009)

Ian Gibson: To ask the Chancellor of the Duchy of Lancaster how many deaths by overdose from drugs in Class (a) A, (b) B and (c) C there were in the last 12 months for which figures are available.

Written Answers — Energy and Climate Change: Energy: Consumption (25 Mar 2009)

Ian Gibson: To ask the Secretary of State for Energy and Climate Change if he will take steps to encourage energy companies to curtail consumer demand for electricity.

Written Answers — Health: Strokes: Health Services (23 Mar 2009)

Ian Gibson: To ask the Secretary of State for Health what recent steps have been taken under the National Stroke Strategy to reduce vascular risk in stroke or trans ischaemic attack patients.

Written Answers — Energy and Climate Change: Carbon Sequestration (23 Mar 2009)

Ian Gibson: To ask the Secretary of State for Energy and Climate Change what recent assessment he has made of the development of carbon capture and storage technologies.

Written Answers — House of Commons Commission: Occupational Health (20 Mar 2009)

Ian Gibson: To ask the hon. Member for North Devon, representing the House of Commons Commission if the Commission will assess the adequacy of provision of occupational health and welfare services in the House for (a) hon. Members and their staff and (b) civil servants who work on the Parliamentary Estate.

Written Answers — Health: Human Papilloma Virus (20 Mar 2009)

Ian Gibson: To ask the Secretary of State for Health (1) if he will commission research into the effectiveness of implementing human papilloma virus testing as a follow-up test for women with borderline and abnormal smear test results and following treatment for cervical abnormalities; and if he will make a statement; (2) if he will increase (a) the amount of funding available for the human papilloma...